BalazsHalmosMD

Clinical Trials

• Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer Start of enrollment: 2007 Jun 01

  Withdrawn

• Lapatinib Resistance in Patients With Breast Cancer Start of enrollment: 2008 Jul 01

  Withdrawn

• Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14

  Completed

  Phase 3

• Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11

  Terminated

  Phase 3

• A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Start of enrollment: 2014 May 05

  Completed

  Phase 1

• Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08

  Completed

• A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer Start of enrollment: 2015 Aug 06

  Completed

  Phase 2

• Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 Start of enrollment: 2018 May 29

  Terminated

  Phase 2

• Booster Dose Trial Start of enrollment: 2021 Aug 10

  Recruiting

  Phase 2

  Roles: Contact

• Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations Start of enrollment: 2022 Mar 31

  Recruiting

  Phase 1, Phase 2

  Roles: Contact

• A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors Start of enrollment: 2020 Aug 19

  Terminated

  Phase 1, Phase 2

  Roles: Contact

• Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients Start of enrollment: 2023 Apr 01

  Not yet recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Join now to see all